| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.34▲ | 2.34▲ | 2.37▼ | 2.19▲ | 2.08▲ |
| MA10 | 2.34▲ | 2.37▼ | 2.35▼ | 2.06▲ | 1.94▲ |
| MA20 | 2.34▲ | 2.32▲ | 2.23▲ | 2.04▲ | 1.75▲ |
| MA50 | 2.36▼ | 2.17▲ | 2.05▲ | 1.94▲ | 2.74▼ |
| MA100 | 2.32▲ | 2.03▲ | 2.01▲ | 1.73▲ | 3.48▼ |
| MA200 | 2.21▲ | 2.01▲ | 2.06▲ | 2.17▲ | 2.40▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.009▼ | 0.006▲ | 0.035▲ | 0.148▲ |
| RSI | 52.697▲ | 57.920▲ | 59.156▲ | 63.834▲ | 55.162▲ |
| STOCH | 78.571 | 37.159 | 69.496 | 67.861 | 61.819 |
| WILL %R | 0.000▲ | -53.846 | -25.455 | -22.378▲ | -15.534▲ |
| CCI | 143.156▲ | -28.877 | 39.374 | 197.177▲ | 155.465▲ |
|
Thursday, August 14, 2025 05:05 AM
ISELIN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ...
|
|
Tuesday, July 22, 2025 12:45 AM
Detailed price information for Outlook Therapeutics Inc (OTLK-Q) from The Globe and Mail including charting and trades.
|
|
Friday, July 18, 2025 04:17 AM
FRENCHTOWN, NJ / ACCESS Newswire / July 18, 2025 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced the participating company line up for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 2.50 | 2.50 | 2.22 | 2.34 | 2,694,690 |
| 14/08/25 | 2.03 | 2.46 | 1.945 | 2.43 | 3,158,526 |
| 13/08/25 | 2.10 | 2.24 | 2.06 | 2.13 | 1,654,123 |
| 12/08/25 | 1.98 | 2.19 | 1.94 | 2.09 | 1,740,319 |
| 11/08/25 | 1.94 | 2.01 | 1.92 | 1.96 | 960,456 |
| 08/08/25 | 1.88 | 1.91 | 1.81 | 1.90 | 542,264 |
| 07/08/25 | 1.89 | 1.90 | 1.785 | 1.84 | 818,422 |
| 06/08/25 | 1.98 | 2.00 | 1.8505 | 1.88 | 1,504,055 |
| 05/08/25 | 2.04 | 2.05 | 1.97 | 2.00 | 672,146 |
| 04/08/25 | 1.96 | 2.05 | 1.90 | 2.01 | 1,154,482 |
|
|
||||
|
|
||||
|
|